No, Zoloft (sertraline) is NOT a controlled substance.
Zoloft contains sertraline hydrochloride, which is explicitly not classified as a controlled substance 1. This is clearly stated in the FDA-approved drug labeling under the Drug Abuse and Dependence section.
Key Points About Zoloft's Regulatory Status
DEA Classification: Sertraline has no DEA schedule classification, meaning it is not subject to the same prescribing restrictions as controlled substances like benzodiazepines, opioids, or stimulants 1.
Abuse Potential: In controlled studies comparing sertraline to known substances of abuse (alprazolam and d-amphetamine), sertraline did not produce the positive subjective effects indicative of abuse potential, such as euphoria or drug liking 1. This lack of reinforcing properties is why it remains unscheduled.
Clinical Implications
Prescribing flexibility: Because sertraline is not a controlled substance, physicians can:
- Prescribe it without special DEA registration requirements
- Provide refills without the limitations imposed on controlled medications
- Transfer prescriptions between pharmacies more easily
Important caveat: While sertraline is not a controlled substance and lacks abuse potential, it can cause discontinuation syndrome when stopped abruptly, particularly with short-acting SSRIs 2. This physiological dependence is distinct from the addiction potential seen with controlled substances. Patients should taper gradually rather than stop suddenly to avoid withdrawal symptoms including dizziness, nausea, irritability, and sensory disturbances.
Contrast With Controlled Substances
For context, carisoprodol (Soma) is classified as a controlled substance due to its abuse and addiction potential, with documented escalation of abuse in the past decade 3. Sertraline has no such classification or concerns.